Interview Questions156

    Lockup Expiration and the Post-IPO Quiet Period

    IPO lockups prevent pre-IPO shareholders from selling for 180 days; a separate post-IPO quiet period governs when analysts can initiate coverage.

    |
    8 min read
    |
    3 interview questions
    |

    Introduction

    The IPO lockup is a contractual restriction that prohibits pre-IPO shareholders from selling their shares for a period of time after listing, typically 180 days. The lockup protects the newly-public market from oversupply during the most fragile post-IPO window, supports the syndicate desk's stabilization activity, and gives the issuer's stock time to find a stable trading range before insider selling pressure arrives. The post-IPO quiet period under FINRA Rule 2241 is a separate but related restriction governing when underwriter research analysts can publish on the newly-listed stock. This article walks through how the lockup actually works, the recent trend toward early-release mechanics in technology IPOs, and the quiet-period rules that shape post-IPO research coverage.

    Inside the 180-Day Lockup

    The lockup is a contractual arrangement between the issuer, the underwriters, and the pre-IPO shareholders. It runs from pricing for a defined period, restricts specified parties from selling, and can include early-release provisions that activate under specific conditions.

    Who the Lockup Covers

    The standard lockup applies to all pre-IPO shareholders, including founders, directors, executive officers, employees holding restricted stock or options, pre-IPO sponsors (private equity and venture capital), and other significant pre-IPO investors. The selling shareholders who participated in the IPO secondary tranche are also subject to lockup on their remaining post-IPO holdings. The new investors who received IPO allocations are not subject to lockup (they bought freely-tradeable shares); they can sell whenever they choose.

    Prohibited Activities: Sale, Transfer, Hedge, Pledge

    The lockup typically prohibits selling, transferring, hedging, or otherwise disposing of the locked-up shares for the lockup period. Pledges of shares as collateral, hedging through options or other derivatives, and economic transfers through total return swaps are all generally prohibited. The lockup language in the underwriting agreement and the lockup letters signed by individual shareholders defines the specific prohibitions.

    Why 180 Days

    The 180-day standard emerged in the 1990s as a compromise between underwriter preferences for longer lockups and shareholder preferences for earlier liquidity. The duration aligns with one annual reporting cycle, allowing the company to deliver one or two quarterly earnings calls before insider selling pressure begins. Recent practice shows variation, with some technology issuers shortening to 120 days and some sponsor-backed deals extending to 270 days for specific shareholders.

    Free Float and Restricted Shares

    The lockup framework defines which shares are tradable at IPO and which are restricted. The free float (also called the public float) consists of the shares allocated to new IPO investors plus any pre-IPO holdings not subject to the lockup; the locked-up shares of pre-IPO insiders count as restricted for the lockup period.

    Free Float=Total Shares OutstandingRestricted Shares\text{Free Float} = \text{Total Shares Outstanding} - \text{Restricted Shares}
    Float %=Free FloatTotal Shares Outstanding\text{Float \%} = \frac{\text{Free Float}}{\text{Total Shares Outstanding}}

    A lower free float at IPO concentrates trading among the IPO investors and tends to amplify volatility because less supply absorbs demand swings. As the lockup expires and restricted shares become tradable, the free float expands, which is part of why lockup expiration is monitored as a supply event.

    Early-Release Mechanics

    Recent technology IPOs have introduced creative early-release structures that let employees and other insiders access liquidity sooner than the full 180-day window.

    Price-Trigger Early Releases

    Many recent technology IPOs include a price-trigger provision releasing a portion of locked-up shares (typically 10 to 25 percent of an individual's holding) once the stock has traded above a specified premium to the IPO price (typically 25 to 50 percent above) for a sustained period (typically 10 consecutive trading days). The trigger lets employees who joined the company expecting to access liquidity through an IPO actually access it without waiting six months. Reddit, Airbnb, and similar deals have used variants of this structure.

    Post-Earnings Releases

    Other deals release portions of the lockup after the issuer's first or second post-IPO earnings release, conditional on the release falling at least 90 to 120 days post-pricing. The trigger ensures the market has digested at least one quarter of public reporting before insider selling begins, while accelerating liquidity relative to the strict 180-day window.

    Managed Selling Programs and 10b5-1 Plans

    Larger or more sponsor-driven deals often structure Rule 10b5-1 plans that let specified insiders sell pre-defined quantities at pre-defined prices on a schedule established before lockup expiration. The plans control selling pressure and reduce the risk of clustered insider sales hitting the market simultaneously.

    Rule 10b5-1 Plans Post-2023 Amendments

    The SEC adopted significant amendments to Rule 10b5-1 on December 14, 2022, with compliance required for Section 16 reporting persons on Form 4 / 5 filings on or after April 1, 2023. The amendments materially restructure the affirmative defense available to insiders trading on a pre-arranged schedule.

    90-Day Cooling-Off Period for Officers and Directors

    The amendments impose a mandatory cooling-off period before the first trade under a newly-adopted or modified plan can occur. For directors and officers, the cooling-off period is the later of (1) 90 days after plan adoption or modification or (2) 2 business days after the issuer's Form 10-Q or 10-K covering the quarter of plan adoption is filed, capped at 120 days. For other employees and persons, the cooling-off period is 30 days. Issuers themselves are not subject to a mandatory cooling-off period under the amendments.

    Single-Plan and Overlapping-Plan Restrictions

    The amendments prohibit overlapping 10b5-1 plans (an insider cannot simultaneously have multiple plans for purchases or sales of the same class of securities) and limit single-trade plans (an insider can rely on the affirmative defense for at most one "single-trade" plan in any 12-month period). The restrictions close two of the most-criticized abuse patterns in the prior framework.

    Good-Faith Certification

    Directors and officers must certify at plan adoption or modification that (1) they are not aware of material non-public information about the issuer or its securities, and (2) they are adopting the plan in good faith and not as part of a scheme to evade Rule 10b-5. The certification gets included in the plan documents and supports the affirmative defense's continued availability.

    Disclosure Requirements

    Form 4 and 5 filings now require a checkbox indicating whether a reported transaction was made under a plan intended to satisfy 10b5-1's affirmative defense, plus the plan's adoption date. Regulation S-K Item 408(a) requires quarterly issuer disclosure of the adoption or termination of any 10b5-1 plan by directors and officers, including the insider's name and title, plan adoption or termination date, plan duration, and aggregate securities to be purchased or sold. The disclosure transparency is one of the principal investor-protection elements of the amendments.

    Effect on Post-IPO Insider Sales

    Post-IPO issuers planning to use 10b5-1 plans for insider sales must build the 90-day cooling-off period plus the post-quarterly-report timing constraint into the lockup-expiration calendar. A 180-day standard lockup expiring around the same window as the issuer's first or second post-IPO 10-Q filing creates natural plan-adoption opportunities, but the working group has to coordinate the timing carefully to avoid the cooling-off period extending insider liquidity well past the lockup expiration date.

    Lockup Agreement

    A contractual restriction signed by pre-IPO shareholders (founders, directors, executives, employees, sponsors, and major investors) prohibiting them from selling, transferring, or hedging their shares for a defined period after the IPO, typically 180 days. The lockup is required in the underwriting agreement and individually executed lockup letters. Modern lockup agreements increasingly include early-release provisions tied to stock-price triggers or post-earnings dates that give some shareholders earlier liquidity.

    The Post-IPO Research Quiet Period

    Separate from the lockup, FINRA Rule 2241 imposes a quiet period on the underwriter banks' research analysts: they cannot publish a research report or make a public appearance about the issuer for a defined window after pricing.

    The 10-Day Standard

    The standard quiet period is 10 days for managers and co-managers of an IPO, reduced from 40 days under FINRA Rule 2241, adopted in 2015. The reduction reflected the policy view that allowing earlier research coverage benefits investors by making sell-side analyst views available faster. After the 10-day quiet period expires, the underwriter analysts can publish initiation reports, make public appearances, and discuss the issuer publicly.

    The Emerging Growth Company Exception

    For emerging growth companies (the majority of US IPO candidates under the JOBS Act), there is no post-IPO research quiet period at all. Underwriter analysts on EGC IPOs can publish immediately after pricing, even on the first day of trading. The exception was designed to accelerate sell-side coverage of smaller companies, on the theory that earlier research benefits investors more than the conflict-of-interest risks justify a quiet period.

    The lockup governs insider supply; the quiet period governs research voice. Both reach the end of their windows in the months after listing, leaving the stock to trade on its own. The first published sell-side voice comes through research coverage initiation, where analysts publish their first initiation reports and the syndicate banks coordinate their coverage rollout.

    Interview Questions

    3
    Interview Question #1Easy

    What is an IPO lockup, and why is it 180 days?

    A lockup is a contractual restriction (signed in the underwriting agreement) preventing pre-IPO shareholders (founders, employees, sponsors) from selling shares for a defined period after the IPO. The typical period is 180 days.

    The 180-day window covers two earnings reports (Q1 and Q2), giving the public market time to digest the company's first quarters as a public issuer before insiders can sell. It also reduces post-IPO selling pressure during the most volatile period for newly listed stock.

    Lockups are written into the underwriting agreement as a covenant, with carve-outs for pre-existing 10b5-1 plans, charitable donations, estate-planning transfers, and (sometimes) pre-defined "early-release" tranches keyed to stock-price triggers.

    Interview Question #2Medium

    What happens to the stock around lockup expiration, and why?

    Stocks frequently dip into lockup expiration as the market anticipates supply. The typical pattern: 5 to 15% drift down in the 2 to 4 weeks before expiry, modest selling pressure on the day, and then recovery if fundamentals are intact.

    The size of the move depends on (1) how much locked-up stock will become free (50% of the float entering the market is dramatically different from 5%), (2) likelihood of insider selling (sponsors will sell; founders often will not), (3) the stock's performance since IPO (deep losers see less selling because insiders won't sell at depressed prices), and (4) whether secondary follow-on offerings are pre-arranged.

    Banks frequently structure orderly secondary follow-ons or block trades coincident with lockup expiry, so insiders sell into a single distributed transaction rather than dribbling shares into the market.

    Interview Question #3Medium

    A company IPO'd 18 months ago at $35. Pre-IPO holders own 100M shares (excluding the 50M sold in the IPO). At the 180-day lockup expiry, 60% of those holders sold via a follow-on at $52. At the 12-month lockup re-mark, another 25% of the original pre-IPO holders sold via blocks at $48 average. Stock now trades at $55 with 18 months since IPO. How many shares are still locked or restricted, and how much capital have insiders monetized?

    Pre-IPO holder share count at IPO: 100M.

    At 180-day expiry: 60% × 100M = 60M shares sold at $52 = $3.12B monetized.

    Remaining locked or held at 6 months: 40M shares.

    At 12 months: 25% × 100M = 25M shares sold via blocks at $48 = $1.2B monetized.

    Remaining held: 40M − 25M = 15M shares.

    Total monetized to date: $3.12B + $1.2B = $4.32B.

    Implied gain vs IPO price: insiders held shares worth $35 × 85M sold = $2.975B at IPO price; sold for $4.32B, a $1.345B premium above IPO-price value.

    Of remaining 15M shares at current $55 price: worth $825M at current market.

    Total realized + unrealized capital from pre-IPO holdings: $4.32B realized + $0.825B unrealized = $5.145B, vs IPO-price value of $35 × 100M = $3.5B. Insiders captured a 47% premium on the position by selling into the post-IPO rally.

    Explore More

    Sponsor Cases vs Strategic M&A: Key Differences

    Understand the fundamental differences between financial sponsor (PE-backed) deals and strategic M&A, including deal structure, leverage, valuation approach, and process implications for investment banking.

    November 7, 2025

    How to Answer "What's Your Greatest Accomplishment?" in IB

    Master the accomplishment question in investment banking interviews. Learn to select the right story, structure your answer with impact, and showcase skills banks value.

    December 14, 2025

    Tender Offers Explained: How They Work in M&A

    Tender offers in M&A explained. Williams Act, DGCL Section 251(h), minimum tender conditions, and examples from Gilead/Immunomedics and Merck/Acceleron.

    April 20, 2026

    Ready to Transform Your Interview Prep?

    Join 3,000+ students preparing smarter

    Join 3,000+ students who have downloaded this resource